| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.08 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.08 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.08 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.077 | 0.08 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.09 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.095 | 0.09 |